focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,146.00
Bid: 12,144.00
Ask: 12,146.00
Change: -20.00 (-0.16%)
Spread: 2.00 (0.016%)
Open: 12,186.00
High: 12,198.00
Low: 12,114.00
Prev. Close: 12,166.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON BRIEFING: UK public sector borrowing shoots up in November

Wed, 21st Dec 2022 07:55

(Alliance News) - Stock prices in London were called to open higher on Wednesday, after a positive finish on Wall Street.

In early economic news, public sector net borrowing in the UK jumped in November due to the energy support scheme, according to the Office of National Statistics.

It reached a total of GBP21.20 billion, surpassing the GBP13.37 billion in October, which was revised upwards from GBP12.73 billion.

"Public borrowing was boosted in November by the government's energy and cost of living interventions, the decision to reverse April's National Insurance hike, and high inflation," said Pantheon Macroeconomics' Samuel Tombs.

"The Energy Bills Support Scheme cost the government GBP1.9 billion in November, while the Energy Price Guarantee was the main driver of a GBP4.7 billion year-over-year rise in subsidies. In addition, social assistance payments were GBP3.3 billion higher than a year ago, reflecting the payment of the second Cost of Living grants to working-age benefit recipients," Tombs continued.

Meanwhile, consumer confidence in Germany is expected to improve for the third month in a row in January.

The latest GfK forecast is minus 37.8 points for its consumer sentiment index, which is up 2.3 points from the revised figure of minus 40.1 points in December.

Economic and income expectations have improved, as has the propensity to buy.

"The consumer sentiment is thus continuing its cautious recovery. More moderate energy prices than originally expected and the German government's relief packages to curb energy costs are responsible for the decreased pessimism," GfK explained.

In early corporate news, Bunzl said it expects double-digit revenue growth in 2022, while AstraZeneca won two new drug approvals in the EU.

Here is what you need to know ahead of the London market open:

----------

MARKETS

----------

FTSE 100: called up 25.5 points, 0.4%, at 7,396.12

----------

Hang Seng: down 0.1% at 19,079.08

Nikkei 225: closed down 0.7% at 26,387.72

S&P/ASX 200: closed up 1.3% at 7,115.10

----------

DJIA: closed up 92.20 points, or 0.3%, at 32,849.74

S&P 500: closed up 3.96 points, or 0.1%, at 3,821.62

Nasdaq Composite: closed up just 1.08 points at 10,547.11

----------

EUR: lower at USD1.0613 (USD1.0627)

GBP: higher at USD1.2156 (USD1.2139)

USD: lower at JPY132.24 (JPY131.27)

GOLD: lower at USD1,814.06 per ounce (USD1,814.62)

OIL (Brent): flat at USD80.31 a barrel (USD79.88)

(changes since previous London equities close)

----------

ECONOMICS

----------

Wednesday's key economic events still to come:

11:00 GMT UK CBI distributive trades survey

07:00 EST US MBA weekly mortgage applications survey

10:00 EST US consumer confidence index

----------

An estimated 1.9 million UK households have missed payments in the run-up to Christmas, according to Which? The consumer group combined the findings from a survey of 2,000 people with population figures to make the calculations. The survey found that around 6.7% of households had missed or defaulted on at least one mortgage, rent, bill or credit payment in the past month in December – which could equate to 1.9 million households if the findings were projected across the UK.

----------

Ukraine's President Volodymyr Zelensky will meet US leader Joe Biden and address Congress in Washington on Wednesday, a visit the White House said will send Russia a strong message of Western unity. The secretly arranged trip comes on the same day Russian President Vladimir Putin plans to meet his top military officials to assess the dire results so far of the war on Ukraine and set goals for next year. The visit will "underscore the US' steadfast commitment to supporting Ukraine for as long as it takes," White House spokeswoman Karine Jean-Pierre said in a statement. It will be Zelensky's first trip outside Ukraine since Russian forces invaded in February.

----------

BROKER RATING CHANGES

----------

Citigroup cuts British Land price target to 388 (526) pence - 'neutral'

----------

RBC raises Close Brothers price target to 1,350 (1,100) pence - 'outperform'

----------

COMPANIES - FTSE 100

----------

Bunzl said it expects to deliver strong growth in 2022, with revenue set to grow 17% year-on-year. This is due to "inflation driving underlying revenue growth and the impact of acquisitions further supplementing growth", the distribution services firm said. Bunzl said its operating margin is expected to be slightly ahead of prior guidance, and will be in line with 2021. Looking ahead to 2023, Bunzl expects revenue to grow slightly, with adjusted operating profit to be "resilient". Adjusted earnings per share are expected to be "moderately" lower from 2022, however. "Negotiations with our largest customer by revenue are ongoing," Bunzl noted.

----------

AstraZeneca received approvals for Lynparza and Imfinzi in the EU. Lynparza, or olaparib, has been approved as a combination treatment for the treatment of metastatic castration-resistant prostate cancer. The approval was based on the results from its Propel phase III trial. Imfinzi, or durvalumab, has been approved as a first-line treatment in combination with chemotherapy for unresectable or metastatic biliary tract cancer. The approval is based on primary results from the Topaz-1 phase III trial.

----------

Anglo American said De Beers rough diamond sales amounted to USD410 million in its tenth sales cycle of 2022, which was down from USD454 million in cycle nine. It was up from USD336 million in the tenth cycle of 2021, however. "Demand for our rough diamonds over the final sales cycle of 2022 was in line with expectations, ahead of the normal seasonal closure of polishing factories in southern Africa over the Christmas period and with Sightholders taking a prudent approach ahead of restocking after Christmas and the expected re-opening of the China market," said CEO Bruce Cleaver. The figures for cycle 10 remain subject to adjustment.

----------

COMPANIES - FTSE 250

----------

Ferrexpo said it is now receiving sufficient power levels to bring one pelletiser line back into operation in Ukraine. "This will allow the group, together with its stockpiled material, to meet the requirements of existing customer contracts," it explained. The iron pellet producer had suspended its operations in central Ukraine back in October. Ferrexpo said it has produced around 300,000 tonnes of pellets in the fourth quarter so far, and expected total pellet production for 2022 to be around 5.9 to 6.0 million tonnes. "Despite interruptions to the group's production, shipments to customers during 4Q 2022 have continued at a run rate of approximately 250 kilotonnes per month," it noted.

----------

Security contractor Serco will be sentenced later for health and safety failings that led to a mentally-ill prisoner kicking a custody officer to death. Humphrey Burke, now 29, attacked 54-year-old Lorraine Barwell as she tried to escort him from his cell in Blackfriars Crown Court in central London in June 2015. Burke admitted manslaughter by diminished responsibility and was handed an indefinite hospital order at the Old Bailey in January. Barwell's employer, Serco, which is contracted by the Ministry of Justice to provide security services in courts, pleaded guilty in April to one count of failure to discharge general health, safety and welfare duty from January 2014 to March 2017.

----------

OTHER COMPANIES

----------

Directa Plus announced a "new significant" contract with European speciality chemical and ingredient distributor Pigmentsolution. The producer and supplier of graphene nanoplatelets based products said it will support the development of its new Grafyshield G+ product in Europe. The contract will initially run for 12 months from January, in Germany, Austria, Switzerland and Poland. The contract will enable "Directa Plus to assess these important markets to build a solid basis for 2024", and assess potential expansion across Europe in the longer-term.

----------

Mitsui & Co subsidiary Mitsui USA enters into agreements with Florence Copper for copper cathode offtake and an equity conversion right. Florence plans to produce low-carbon copper cathode in Arizona, and Mitsui will pay USD50 million to cover part of the development costs. Says Florence plans to produce copper using the in-situ recovery for extracting the metal from underground deposits. Expects construction to take 18 months, and then production will start. Florence is a subsidiary of Taseko Mines, which is listed in Toronto, New York and London.

----------

By Elizabeth Winter, Alliance News senior markets reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2022 Alliance News Ltd. All Rights Reserved.

More News
13 Feb 2024 12:06

LONDON MARKET MIDDAY: Stocks fall but pound up before US data

(Alliance News) - Stock prices in London were on the decline on Tuesday afternoon, with sentiment tetchy ahead of a US inflation report later.

Read more
13 Feb 2024 09:32

LONDON BROKER RATINGS: Citi lifts GSK; Shore likes XPS Pensions

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
12 Feb 2024 12:04

LONDON MARKET MIDDAY: FTSE 100 underperforms as European peers rise

(Alliance News) - London's FTSE 100 underwhelmed on Monday, with some of its largest constituents pulling it lower, while indices in Europe were on the up on favourable comments on interest rate cuts by a European Central Bank official.

Read more
12 Feb 2024 09:41

LONDON BROKER RATINGS: Deutsche Bank starts Deliveroo at 'buy'

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
12 Feb 2024 09:12

Barclays sees "compelling" entry point at AstraZeneca after recent falls

(Sharecast News) - Barclays has kept an 'overweight' position on AstraZeneca despite the biopharma group's disappointing annual results last week, saying that the stock's recent underperformance provides an attractive entry point for investors.

Read more
9 Feb 2024 09:15

LONDON BROKER RATINGS: Deutsche Bank cuts AstraZeneca to 'sell'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
9 Feb 2024 07:51

LONDON BRIEFING: Barclays buys Tesco's retail banking business

(Alliance News) - Stocks in London are called to open higher on Friday, closing off a busy corporate week.

Read more
8 Feb 2024 17:00

LONDON MARKET CLOSE: Softer earnings weigh on underperforming FTSE 100

(Alliance News) - London's FTSE 100 ended lower on Thursday, with mixed corporate updates keeping a lid on enthusiasm, while in New York the S&P 500 has the 5,000 point mark in touching distance.

Read more
8 Feb 2024 14:42

London close: Stocks slip as US jobless claims fall

(Sharecast News) - London markets experienced a downturn in trading on Thursday, with stocks relinquishing earlier gains as investors processed a decrease in jobless claims in the United States.

Read more
8 Feb 2024 12:08

LONDON MARKET MIDDAY: DS Smith surges on takeover approach from Mondi

(Alliance News) - Stock prices in London were mixed at midday Thursday, as markets struggled to find direction amid a mixed wave of corporate updates and earnings.

Read more
8 Feb 2024 08:59

LONDON MARKET OPEN: Unilever up on buyback; BAT ups dividend

(Alliance News) - THE FTSE 100 in London opened slightly higher on Thursday, with earnings from British American Tobacco and Unilever boosting the index.

Read more
8 Feb 2024 08:44

TOP NEWS: AstraZeneca confident after 2023 profit more than doubles

(Alliance News) - AstraZeneca PLC on Thursday said it expects another year of strong growth after reporting pretax profit in 2023 more than doubled.

Read more
8 Feb 2024 07:58

AstraZeneca shares slip as Q4 profits miss forecasts

(Sharecast News) - Biopharma titan AstraZeneca delivered a 6% increase in sales in 2023 despite a $3.7bn decline in Covid-19 medicines revenues, as it guided to a strong pick-up in growth this year - though profits came in slightly under analysts' forecasts.

Read more
8 Feb 2024 07:50

LONDON BRIEFING: Unilever sets new buyback; Astra profit surges

(Alliance News) - Stocks in London are called to open slightly higher on Thursday, as investors eye a busy day of earnings.

Read more
2 Feb 2024 08:38

AstraZeneca celebrates latest successful trial of acoramidis in Japan

(Alliance News) - AstraZeneca PLC on Friday said positive results from a Phase 3 trial of acoramidis are consistent with global findings, bring the drug closer to regulatory submission in Japan.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.